drugset / Trial / NCT05195944
Semaglutide vs Sitagliptin
Phase 4
Enrolling by invitation
58 enrolled
University Health Network, Toronto
Novo Nordisk A/S · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The effect of once daily dosing of oral Semaglutide versus once daily dosing Sitagliptin on glycemic control, body weight, and safety and tolerability will be compared in Liver Transplant Recipients with poorly-controlled Diabetes Mellitus.
Timeline
- Start
- 2022-10-26
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Semaglutide | Peptide | 14 mg | Oral |
| Comparator | Sitagliptin | Small molecule | 100 mg | — |